 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

For the last three days, A.I.dvisor has detected that TYRA's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Tyra Biosciences (TYRA, $16.88) Aroon Indicator entered a Downtrend on April 01, 2024.

Tyra Biosciences (TYRA, $16.32) Aroon Indicator entered a Downtrend on March 28, 2024.

Tyra Biosciences (TYRA, $16.32) Aroon Indicator entered a Downtrend on March 27, 2024.

Tyra Biosciences, Inc. (NASDAQ:TYRA  Free Report)  Equities research analysts at HC Wainwright lowered their Q1 2024 EPS estimates for Tyra Biosciences in a research report issued to...

Tyra Biosciences, Inc. to Post Q1 2024 Earnings of ($0.53) Per Share, HC Wainwright Forecasts (NASDAQ:TYRA)

Tyra Biosciences, Inc. (NASDAQ:TYRA  Free Report)  Equities researchers at HC Wainwright issued their FY2025 earnings estimates for Tyra Biosciences in a research report issued on...

HC Wainwright Weighs in on Tyra Biosciences, Inc.'s FY2025 Earnings (NASDAQ:TYRA)

Tyra Biosciences, Inc. (NASDAQ:TYRA  Free Report)  Research analysts at HC Wainwright issued their FY2025 earnings estimates for shares of Tyra Biosciences in a research note issued on...

Analysts Set Expectations for Tyra Biosciences, Inc.'s FY2025 Earnings (NASDAQ:TYRA)

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Tyra Biosciences price target raised by $4 at H.C. Wainwright, here's why

Recent Financial Highlights Indicate Strong Cash Position and Advancements in Clinical StudiesRelated Stocks: TYRA...

Tyra Biosciences Inc (TYRA) Reports Increased R&D Investments Amid Pipeline Progress

Tyra Biosciences GAAP EPS of -$0.53 misses by $0.05...

Tyra Biosciences GAAP EPS of -$0.53 misses by $0.05

Tyra Biosciences files to sell 15.37M shares of common stock for holders...

Tyra Biosciences files to sell 15.37M shares of common stock for holders

Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Its proprietary in-house discovery platform, SNÅP, enables the rapid and precise refinement of structural design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA is developing a pipeline of selective inhibitors of the Fibroblast Growth Factor Receptor (FGFR) family members, which are altered in approximately 7% of all cancers. The company was founded by Daniel Bensen and Todd Harris on August 2, 2018 and is headquartered in Carlsbad, CA.

Volume (M)	192,278.00
52-Wk High	$20.67
52-Wk Low	$10.38

TYRA Tyra Biosciences Inc

About

Feed

News

Sentiment

Earnings

Fundamentals